Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Soleil Organique Relaunches Premier Sunscreens After Trademark Conflict

This article was originally published in The Tan Sheet

Executive Summary

After a trademark snag derailed Valerie McMurray’s first attempt at marketing a sun-care brand, she is back with a chic new line of prestigious, skin-healthy sunscreens targeted to sophisticated consumers.

You may also be interested in...



Schering's Bain de Soleil Purchase Adds Premium Line To Coppertone Stable

Schering-Plough's acquisition of the Bain de Soleil sun care line from Pfizer adds an "established, premium brand" to Schering's sun care portfolio, allowing it "to expand and strengthen" the Coppertone line, Schering announced Oct. 7.

Euromonitor: Value Shopping, Gender-Blurring Among Top Consumer Trends For 2106

A new report from market-research firm Euromonitor International suggests that global consumption in the coming year will see a blend of established, new and counter trends, challenging the way consumers live and shop. Within beauty, marketers may seize on the trends of value shopping, gender-blurring and embracing of aging to reach discriminating consumers in 2016.

P&G Eyes Product Sampling, Trials As Fix For Sagging Sales

Procter & Gamble management highlights product sampling and trials as opportunities to drive home product benefits with consumers at a time when the firm is increasing prices to counter the currency impact of the strong dollar. Analysts pressured P&G CFO Jon Moeller for details on the firm's turnaround following a troublesome quarter.

Topics

UsernamePublicRestriction

Register

LL1135490

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel